日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular mechanism of cholesterol-dependent membrane fusion in SARS-CoV-2 entry

SARS-CoV-2入侵过程中胆固醇依赖性膜融合的分子机制

Li, Wei; Wu, Mengdan; Feng, Shirong; Su, Jiaming; Niu, Qian; Lin, Weijun; Fan, Jiaqi; Cui, Lele; Xiang, Yijuan; Li, Hao; Li, Kaiyu; Su, Zhaoming; Lu, Guangwen; Lai, Ying

Interaction Between Maternal Obesity and Metabolic Dysfunction in Gestational Hypertension and Preeclampsia: A Prospective Birth Cohort Study

母体肥胖与代谢功能障碍在妊娠期高血压和子痫前期中的相互作用:一项前瞻性出生队列研究

Chen, Jiayi; Zhu, Yibing; Liu, Junwei; Li, Qingxiu; Shi, Huimin; Liu, Wenjuan; Gao, Haiyan; Li, Wei; Wu, Zhengqin; Sun, Bin; Zhang, Qian; Li, Haibo

Clinical outcomes of a new modified tubeless cutaneous ureterostomy following radical cystectomy

根治性膀胱切除术后改良型无管皮肤输尿管造口术的临床结果

Huang, Haichao; Ding, Meixuan; Bai, Peide; Li, Wei; Wu, Zhun; Wang, Xuegang; Xing, Jinchun; Wang, Tao; Chen, Bin; Zhang, Kaiyan

Mapping neurophysiological biotypes of postpartum depression and underlying neural and molecular basis

绘制产后抑郁症的神经生理生物型图谱及其潜在的神经和分子基础

Chen, Jin; Liang, Ying; Li, Wei; Wu, Yashi; Chen, Meiling; Tao, Xingping; Zi, Tiyan; Dong, Xudong; Cheng, Bochao; Chen, Kexuan; Wang, Jiaojian

Targeting SERPINB3-MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy.

靶向 SERPINB3-MAPK 轴介导的铜凋亡抵抗可增强抗肿瘤免疫疗法的疗效。

Huang Xiao-Xiao, Xie Cheng-Ke, Mo Yi-Chao, Li Wei, Wu Yong-Ding, Li Zhi-Yuan, Zhang Hao-Xiang, Li Ge, Jin Long, Lin Xin-Quan, Hu Jian-Fei, Chen Yin-Hao, Lin Hong-Yi, Zhu Shun-Cang, Lu Jin-Peng, Zhu Hou-Juan, Wang Wan-Wan, Huang Yi, Wang Zu-Wei, Huang Long, Wang Dan-Feng, Tian Yi-Feng, Liao Cheng-Yu, Chen Shi

SIRT2 Inhibition promotes microglia LC3-associated phagocytosis via NRF2/CD36 after the experimental subarachnoid hemorrhage.

SIRT2 抑制可促进实验性蛛网膜下腔出血后小胶质细胞通过 NRF2/CD36 进行 LC3 相关吞噬作用。

Sheng Bin, Chen Xiangxin, Tao Tao, Sun Jiaqing, Li Wei, Wu Lingyun, Peng Zheng, Li Xiaojian, Zhou Zhengxu, Yu Qian, Ling Yeping, Sherchan Prativa, Flores Jerry J, Tang Jiping, Huang Lei, Hang Chunhua, Zhang John H

The value of PFS36 as a primary endpoint for radiotherapy trials in patients with LACC: individual patient data from the Chinese NCC and validation from 26 RCTs

PFS36 作为 LACC 患者放射治疗试验主要终点的价值:来自中国国家癌症中心的个体患者数据和 26 项 RCT 的验证

Yang, Xi; Zhang, Yuanyuan; Jia, Shuangzheng; Yang, Yong; Zhu, Jie; Li, Wei; Wu, Lingying; An, Jusheng; Huang, Manni

Increased risk of chronic diseases and multimorbidity in middle-aged and elderly individuals with early vision, hearing, or dual sensory impairments: insights from prospective cohort studies and Mendelian randomization analysis

早期视力、听力或双重感官障碍会增加中老年人罹患慢性疾病和多种疾病的风险:前瞻性队列研究和孟德尔随机化分析的启示

Wang, Yaoling; Cheng, Fang; Hou, Niuniu; Tan, Yuting; Zhang, Shaomin; Hou, Yanbing; Guo, Wen; Peng, Jin; Li, Wei; Wu, Jinhui

BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label study

BEBT-209,一种选择性 CDK4 抑制剂,用于治疗 HR+/HER2- 晚期乳腺癌(BECTOP1):一项 1 期、多中心、开放标签研究

Hu, Zhe-Yu; Jiang, Kegang; Tian, Can; Zhang, Fan; Shi, Yehui; Wang, Ying; Li, Wei; Wu, Biao; Ding, Boni; Liu, Liping; Xiao, Huawu; Yang, Xiaohong; Li, Jing; Xie, Ning; Liu, Binliang; Wang, Shouman; Ouyang, Quchang

Correction: Li et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer's Disease. Int. J. Mol. Sci. 2025, 26, 3382

更正:Li 等人,《ADSC 分泌的 LEFTY2 在治疗阿尔茨海默病中的治疗潜力》,《国际分子科学杂志》,2025 年,26,3382。

Li, Wei-Wu; Yang, Hsueh-Hui; Chiou, Tzyy-Wen; Woon, Peng-Yeong; Xu, Yue-Xuan; Tjandra, Cynthia; Wijaya, Ivan; Harn, Horng-Jyh; Lin, Shinn-Zong